AZD3974
/ AstraZeneca
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
December 24, 2025
A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD3974 in Healthy Participants
(clinicaltrials.gov)
- P1 | N=176 | Recruiting | Sponsor: AstraZeneca | Not yet recruiting ➔ Recruiting
Enrollment open • First-in-human
December 19, 2025
A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD3974 in Healthy Participants
(clinicaltrials.gov)
- P1 | N=176 | Not yet recruiting | Sponsor: AstraZeneca
First-in-human • New P1 trial
1 to 2
Of
2
Go to page
1